ESR1 and metabolic dysfunction-associated steatotic liver disease: ERα knockout in mice present with induced steatosis in both sexes, indicating that ERα activation in fibrosis could be a sex-independent protective adaptation against liver insults, exposing estrogen receptor as a potential drug target for NAFLD management [55,56,57].